Disclosures for "Patient-reported Outcomes with Hyaluronidase-facilitated Subcutaneous Immunoglobulin 10% Maintenance Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy"
-
Dr. Anderson-Smits has received personal compensation for serving as an employee of Takeda Pharmaceuticals . Dr. Anderson-Smits has stock in Takeda Pharmaceuticals. The institution of an immediate family member of Dr. Anderson-Smits has received research support from NIH.
-
Dr. A French has received personal compensation for serving as an employee of Takeda.
-
Shabbir Hasan has received stock or an ownership interest from Takeda.
-
Mrs. Greco has nothing to disclose.
-
Dr. AY has received personal compensation for serving as an employee of Takeda.